Giant Molluscum Contagiosum - Symptoms, Causes, Treatment & Prevention

```html

Overview

Molluscum contagiosum is a common, benign viral skin infection caused by a poxvirus (Molluscipoxvirus). In most people the lesions are small—typically 2–5 mm—and resolve spontaneously within 6–12 months. Giant molluscum contagiosum refers to unusually large lesions (≥1 cm) or a massive number of lesions that coalesce into extensive plaques. This form is rare but can be disfiguring and may indicate underlying immune dysfunction.

Who it affects: The infection occurs worldwide and is most prevalent in children aged 1–10 years, sexually active adults, and individuals with weakened immune systems (e.g., HIV‑infected, organ‑transplant recipients, or patients on systemic immunosuppressants). Giant lesions are reported in up to 5 % of immunocompromised patients with molluscum contagiosum, compared with <1 % in immunocompetent hosts.<sup>1</sup>

Prevalence: The CDC estimates that ~5–10 % of the general pediatric population acquires molluscum contagiosum at some point. In the United States, an estimated 1–2 million new cases occur annually.<sup>2</sup> Precise figures for the giant variant are lacking because it is usually reported as case series rather than population‑based studies.

Symptoms

Giant molluscum contagiosum lesions share the classic features of ordinary molluscum but are larger, more numerous, or both. Common signs include:

• Painless, dome‑shaped papules – usually flesh‑colored or pink; in giant lesions they may reach >1 cm and become cauliflower‑like.
• Central umbilication – a small dimple or “plug” in the center, often containing a cheesy, white core.
• Location – trunk, limbs, face, genital area, or, in immunocompromised patients, widespread over the body.
• Itching or irritation – scratching may cause secondary eczema or bacterial infection.
• Bleeding – from trauma or from ulcerated giant lesions.
• Swelling of surrounding tissue – especially when many lesions coalesce.
• Secondary infection signs – redness, warmth, pus, or foul odor indicating bacterial superinfection.
• Systemic symptoms – rare; may include low‑grade fever in the setting of a secondary infection.

Causes and Risk Factors

Cause

Molluscum contagiosum is caused by the Molluscipoxvirus, a DNA virus transmitted through direct skin‑to‑skin contact, sexual contact, or contaminated fomites (e.g., towels, clothing). The virus replicates within the epidermis, producing the characteristic inclusion bodies that give rise to the lesions.

Key risk factors for the giant form

• Immune suppression – HIV infection (particularly CD4 < 200 cells/µL), organ transplantation, chemotherapy, long‑term corticosteroids, biologic agents (TNF‑α inhibitors, rituximab).
• Atopic dermatitis – skin barrier disruption facilitates viral entry.
• Sexual activity – especially unprotected genital contact; the giant form can appear in the anogenital region.
• Close‑contact settings – daycare centers, wrestling teams, schools.
• Skin trauma – scratching, abrasion, or other injuries that breach the epidermis.

Diagnosis

Diagnosis is primarily clinical, based on the characteristic appearance of the lesions. In typical cases, laboratory confirmation is unnecessary, but the following tools may be employed when the presentation is atypical or when giant lesions raise concern for other diagnoses:

Visual examination

• Dermatologic inspection – “pearly” papules with central umbilication.
• Wood’s lamp – generally non‑fluorescent, helps rule out fungal infections.

Dermatoscopy

Reveals central white, curvilinear structures (“molluscum bodies”) surrounded by peripheral vascular patterns.

Biopsy

Indicated when lesions are unusually large, atypical, or fail to respond to standard therapy. Histology shows epidermal hyperplasia with large eosinophilic cytoplasmic inclusion bodies (Henderson-Patterson bodies).

Viral DNA testing

Polymerase chain reaction (PCR) assays on biopsy tissue can confirm the presence of molluscum DNA, though they are rarely needed in practice.

HIV and immune assessment

Given the association with immunosuppression, patients with giant lesions should be screened for HIV (fourth‑generation antigen/antibody test) and have a baseline CBC, CD4 count, and liver/kidney function tests if immunosuppressed.

Treatment Options

Therapy aims to eradicate lesions, reduce transmission, and alleviate symptoms. In immunocompetent patients, a “watch‑and‑wait” approach is often acceptable because lesions resolve spontaneously. Giant or extensive disease, especially in immunocompromised hosts, usually requires active intervention.

Topical agents

• Imiquimod 5% cream – immune response modifier; applied 3 times weekly for up to 16 weeks. Meta‑analysis shows modest clearance rates (≈45 %) but may cause local irritation.<sup>3</sup>
• Podophyllotoxin 0.5% solution – applied twice daily for 3 days, repeated weekly up to 4 weeks. Effective for genital lesions; cautioned against in pregnancy.
• Cryotherapy (liquid nitrogen) – freeze‑thaw cycles (2–3 passes) destroy lesions; may cause temporary hypopigmentation.
• Cantharidin – a vesicant applied by a clinician; induces blistering and lesion resolution in 1–2 weeks.
• Topical retinoids (tretinoin 0.05%–0.1%) – promote epidermal turnover; useful for flat, numerous lesions.

Procedural therapies

• Curettage – mechanical removal with a sharp spoon or curette; high success (>90 %) when performed by an experienced dermatologist.
• Laser therapy – CO₂ or pulsed‑dye laser; effective for giant or hypertrophic lesions, especially on the face.
• Electrocautery – high‑frequency current to vaporize tissue; may be combined with curettage.
• Intralesional interferon‑α – injected into large lesions; reserved for refractory cases.

Systemic therapy (immunocompromised patients)

• Antiretroviral therapy (ART) – in HIV‑positive patients, immune restoration often leads to rapid clearance of lesions.<sup>4</sup>
• Oral cimetidine – histamine‑2 antagonist with immunomodulatory effects; limited evidence.
• Systemic retinoids (acitretin) – used for severe, widespread disease; monitor liver function and lipids.

Lifestyle & supportive care

• Keep lesions covered with breathable dressings to reduce spread.
• Avoid scratching; use antihistamines for itching.
• Maintain good skin hygiene; wash hands frequently.

Living with Giant Molluscum Contagiosum

While the condition is benign, its visible nature can affect self‑esteem and daily activities. Practical tips for coping include:

• Clothing choices – wear loose, cotton garments to reduce friction and irritation.
• Skin care routine – use mild, fragrance‑free cleansers; pat skin dry rather than rubbing.
• Wound care – apply over‑the‑counter antibiotic ointment (e.g., bacitracin) if a lesion becomes ulcerated.
• Emotional support – consider counseling or support groups, especially for adolescents.
• Sexual health – disclose the condition to partners; use condoms to lower transmission risk.
• Follow‑up schedule – see a dermatologist every 4–6 weeks until lesions clear or stabilize.

Prevention

Because the virus spreads by contact, preventive measures focus on reducing exposure and maintaining skin integrity:

• Do not share towels, razors, clothing, or sex toys.
• Cover existing lesions with waterproof dressings during sports or swimming.
• Practice safe sex (condoms, dental dams) and get regular STI screenings.
• In daycare or school settings, encourage daily hand‑washing and avoid sharing personal items.
• Promptly treat skin conditions that compromise the barrier (eczema, psoriasis).
• For immunocompromised patients, adhere strictly to ART or immunosuppressive medication regimens and attend routine monitoring.

Complications

Although molluscum contagiosum is non‑malignant, complications can arise, especially with giant lesions:

• Secondary bacterial infection – cellulitis, impetigo, or abscess formation; may require oral antibiotics.
• Scarring – from aggressive scratching or repeated curettage.
• Psychosocial impact – anxiety, depression, or social isolation due to cosmetic concerns.
• Spread to other body sites – autoinoculation is common, especially in children.
• Indicator of underlying immunodeficiency – giant lesions often signal uncontrolled HIV, neoplasia, or iatrogenic immunosuppression.

When to Seek Emergency Care

---

```